Keyword: Celltrion


Private Equity Steps up for Baxter Biopharma

09.05.2023 -

A private equity consortium of Warburg Pincus and Advent International is said to be in advanced talks to acquire medical device maker Baxter International’s biopharma...


Baxter Said to Eye Sale of Biopharma CMO Arm

22.03.2023 -

Plans by US healthcare company Baxter International to shed its biopharma contract business as it streamlines operations after a poor 2022 earnings performance are...


Lonza to Produce Biosimilar for Celltrion

05.09.2019 - Swiss fine chemicals producer Lonza has signed a contract manufacturing agreement with Korea-based biosimilars producer Celltrion to supply a drug substance for Remsima, a...


Mundipharma to Launch Biosimilar Truxima in Europe

28.02.2017 - UK pharmaceutical group Mundipharma is gearing up to launch Truxima (rituximab), a biosimilar from South Korea’s Celltrion, for the treatment of certain cancers and inflammatory...


The Biosimilar Market

07.02.2014 - Pharmaceuticals - Many biologic drug developers can be pleased with how well their products have performed in the market place. Blockbuster products such as Abbvie's (ex-Abbott)...


European Medicines Agency Pave Way for Biosimilar Drug Breakthrough

01.07.2013 - European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid...